Get notified of page updates

Study: Does lumpectomy or mastectomy provide better survival for women with early stage breast cancer?

Previous research has hinted that women who have breast-conserving surgeries have the same, if not better, overall survival as women who have mastectomies. Researchers in this study wanted to see if that was true; they found that women who chose breast-conserving surgeries did have a higher overall survival. However, this study, presented at the 2015 San Antonio Breast Cancer Symposium, had limitations that make it difficult to interpret the results or to extend them to all women with breast cancer. (01/19/2016)

Glossary on
off

Contents

At a glance In-depth
Findings     Limitations             
Questions for your doctor Resources  


STUDY AT A GLANCE

This study is about:

Whether survival is better for women with breast cancer who opted for breast-conserving surgery (surgery that only removes part of the breast, such as a ) compared to women who had mastectomies.

Why is this study important?

Knowing the positives and negatives of the surgical options for women who are diagnosed with early-stage breast cancer is important. For example, research has shown that women who have mastectomy and reconstruction have many more complications than women who opt for lumpectomy and whole breast irradiation.  Also, the cost of breast-conserving surgery is usually less than the cost of mastectomy. But which surgery has better survival? That is one of the most important things to consider when deciding on a surgical treatment.

Study findings: 

  1. Women who had breast-conserving surgery had increased 10-year survival compared to women who got mastectomies. 

What does this mean for me?

While this data is interesting, it does not change care guidelines for women with early-stage breast cancer. Women should still decide what surgery they want based on their personal preference and all of the characteristics of their cancer. It is important to note that this study did not take into consideration whether or not the women had mutations in or other genes that are associated with an increased risk of a second breast cancer.

Posted 1/19/16

References

van Maaren M, et al. “Higher 10-year overall survival after breast-conserving therapy compared to mastectomy in early-stage breast cancer: A population-based study with 37,207 patients.” Presented December 2015 at the San Antonio Breast Cancer Symposium. 

Disclosure

FORCE receives funding from industry sponsors, including companies that manufacture cancer drugs, tests and devices. All XRAYS articles are written independently of any sponsor and are reviewed by members of our Scientific Advisory Board prior to publication to assure scientific integrity.

Expert Guidelines

The American Society of Breast Surgeons (ASBrS) provides practice guidelines for lumpectomy and mastectomy.

ASBrS recommendations for lumpectomy:

  • Current indications for breast-conserving surgery (BCS) are:
    • A biopsy-proven diagnosis of or invasive breast cancer that is clinically assessed as resectable (can be remove with surgery) with clear margins and with an acceptable cosmetic result.
  • Current contraindications for BCS:
    • Early pregnancy.
    • Multicentric tumor involving 2 or more quadrants of the breast.
    • Diffuse (widely spread) malignant/indeterminate microcalcifications.
    • Inflammatory breast cancer.
    • Persistently positive margins of excision (surgical margins are not clear of cancer cells).

ASBRrS recommendations for mastectomy:

  • Current indications for mastectomy:
    • Any cancer unsuitable for breast conservation, based on:
      • Large tumor-to-breast-size ratio
      • Multicentric tumor
      • Insufficient response to chemotherapy or endocrine therapy  
      • Persistently positive margins of excision
      • Inflammatory breast cancer
      • Extensive malignant/indeterminate microcalcifications
      • Early pregnancy
      • Proven or suspected inherited gene mutation 
      • Local recurrence following breast-conserving surgery and radiation therapy 
      • Patients with a contraindication to radiation 
    • For risk reduction in high-risk patients:
      • Proven or suspected inherited gene mutation 
    • History of prior mantle radiation  

Updated: 01/10/2022

Questions To Ask Your Doctor

  • How do I decide which surgery is right for me?
  • I have been diagnosed with breast cancer before age 50, should I consider genetic testing before deciding on mastectomy or lumpectomy?

Peer Support

The following organizations offer peer support services for people with or at high risk for breast cancer:

Updated: 05/07/2024

Who covered this study?

TIME

With early breast cancer treatment, less may be more: studies This article rates 4.5 out of 5 stars

Health Day

Lumpectomy plus radiation may beat mastectomy for early breast cancer This article rates 4.5 out of 5 stars

General Surgery News

More evidence supports breast conservation over mastectomy This article rates 4.0 out of 5 stars

Medscape

Ten-year data: Lumpectomy and radiotherapy trump mastectomy This article rates 3.5 out of 5 stars

How we rated the media